Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen.

Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. Am J Obstet Gynecol. 1984 Jul 01; 149(5):553-9.

View in: PubMed

subject areas

Adenocarcinoma
Adenocarcinoma, Mucinous
Antibodies, Monoclonal
Antigens, Neoplasm
Antigens, Tumor-Associated, Carbohydrate
Carcinoembryonic Antigen
Carcinoma
Cystadenocarcinoma
Endometriosis
Epitopes
Female
Humans
Monitoring, Physiologic
Ovarian Neoplasms
Radioimmunoassay
Reagent Kits, Diagnostic
Time Factors

authors with profiles

ROBERT C BAST JR